OSUR
$2.98-0.16 (-4.95%)
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapi...
Recent News
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary
Moby summary of OraSure Technologies, Inc.'s Q4 2025 earnings call
OraSure Technologies Q4 Earnings Call Highlights
OraSure Technologies (NASDAQ:OSUR) reported fourth-quarter 2025 revenue of $26.8 million, with management pointing to early signs of stabilization across key end markets after what it described as a transition year marked by a challenging funding environment. On the company’s earnings call, executiv
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights: Revenue Exceeds Expectations ...
Despite operating losses, OraSure Technologies Inc (OSUR) showcases strong revenue performance and strategic product expansions for 2026.
OraSure: Q4 Earnings Snapshot
OSUR) on Wednesday reported a loss of $19.3 million in its fourth quarter. On a per-share basis, the Bethlehem, Pennsylvania-based company said it had a loss of 27 cents. Losses, adjusted for non-recurring costs and stock option expense, were 19 cents per share.
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates
Phibro (PAHC) delivered earnings and revenue surprises of +27.01% and +4.72%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?